Isolation of early hematopoietic cells, including megakaryocyte progenitors, in the ALDH-bright cell population of cryopreserved, banked UC blood

Cytotherapy

Volumn 9, Issue 6, 2007, Pages 569-576

  Gentry, T ^a   Deibert, E ^a   Foster, S J ^a   Haley, R ^a   Kurtzberg, J ^b   Balber, Andrew E ^a  

^a Aldagen Inc   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Aldehyde dehydrogenase; Cell sorting; Hematopoietic progenitor cell; Megakaryocyte progenitor; Umbilical cord blood

Indexed keywords

ALDEHYDE DEHYDROGENASE; CD133 ANTIGEN; CD14 ANTIGEN; CD34 ANTIGEN; GLYCOPHORIN A;

ANTIGEN EXPRESSION; ARTICLE; CELL ISOLATION; CELL POPULATION; CELL VIABILITY; COLONY FORMING UNIT; CONTROLLED STUDY; CRYOPRESERVATION; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; FREEZE THAWING; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; IMMUNOMAGNETIC SEPARATION; MEGAKARYOCYTE; PRIORITY JOURNAL; UMBILICAL CORD BLOOD;

ALDEHYDE DEHYDROGENASE; ANTIGENS, CD; CELL SEPARATION; CRYOPRESERVATION; FETAL BLOOD; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELLS; HUMANS; MEGAKARYOCYTES; TISSUE BANKS;

EID: 34648816714     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.1080/14653240701466347     Document Type: Article

References (20)

1. Storms, RW, Trujillo, AP and Springer, JB (1999) Isolation of primitive human hematopoietic progenitors on the basis of aldehyde dehydrogenase activity. Proc Natl Acad Sci USA, 96, pp. 9118-9123.
2. Hess, DA, Meyerrose, TE and Wirthlin, L. (2004) Functional characterization of highly purified human hematopoietic repopulating cells isolated according to aldehyde dehydrogenase activity. Blood, 104, pp. 1648-1655.
3. Storms, RW, Green, PD and Safford, KM (2005) Distinct hematopoietic progenitor compartments are delineated by the expression of aldehyde dehydrogenase and CD34. Blood, 106, pp. 95-102.
4. Hess, DA, Wirthlin, L. and Craft, TP (2006) Selection based on CD133 and high aldehyde dehydrogenase activity isolates long-term reconstituting human hematopoietic stem cells. Blood, 107, pp. 2162-2169.
5. Fallon, P., Gentry, T. and Balber, AE (2003) Mobilized peripheral blood SSCloALDHbr cells have the phenotypic and functional properties of primitive haematopoietic cells and their number correlates with engraftment following autologous transplantation. Br J Haematol, 122, pp. 99-108.
6. Lioznov, MV, Freiberger, P. and Kroger, N. (2005) Aldehyde dehydrogenase activity as a marker for the quality of hematopoietic stem cell transplants. Bone Marrow Transplant, 35, pp. 909-914.
7. Gentry, T., Foster, SJ and Winstead, L. (2007) Simultaneous isolation of human bone marrow hematopoietic, endothelial and mesenchymal progenitor cells by flow sorting based on aldehyde dehydrogenase activity: implications for cell therapy. Cytotherapy, 9, pp. 259-274.
8. Staba, SL, Escolar, ML and Poe, M. (2004) Cord-blood transplants from unrelated donors in patients with Hurler's syndrome. N Engl J Med, 350, pp. 1960-1969.
9. Martin, PL, Carter, SL and Kernan, NA (2006) Results of the cord blood transplantation study (COBLT): Outcomes of unrelated donor umbilical cord blood transplantation in pediatric patients with lysosomal and peroxisomal storage diseases. Biol Blood Marrow Transplant, 12, pp. 184-194.
10. Locatelli, F., Rocha, V. and Chastang, C. (1999) Factors associated with outcome after cord blood transplantation in children with acute leukemia. Eurocord Cord Blood Transplant Group. Blood, 93, pp. 3662-3671.
11. Kurtzberg, J., Laughlin, M. and Graham, ML (1996) Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients. N Engl J Med, 335, pp. 157-166.
12. Laughlin, MJ, Eapen, M. and Rubinstein, P. (2004) Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. N Engl J Med, 351, pp. 2265-2275.
13. Brunstein, CG and Wagner, JE. (2006) Umbilical cord blood transplantation and banking. Annu Rev Med, 57, pp. 403-417.
14. Rocha, V. and Gluckman, E. (2006) Clinical use of umbilical cord blood hematopoietic stem cells. Biol Blood Marrow Transplant, 12, pp. 34-41.
15. Jones, RJ, Zuehlsdorf, M. and Rowley, SD (1987) Variability in 4-hydroperoxycyclophosphamide activity during clinical purging for autologous bone marrow transplantation. Blood, 70, pp. 1490-1494.
16. Kastan, MB, Schlaffer, E. and Russo, JE (1990) Direct demonstration of elevated aldehyde dehydrogenase in human hematopoietic progenitor cells. Blood, 75, pp. 1947-1950.
17. Gordon, MY, Goldman, JM and Gordon-Smith, EC. (1985) 4-Hydroperoxycyclophosphamide inhibits proliferation by human granulocyte-macrophage colony-forming cells (GM-CFC) but spares more primitive progenitor cells. Leuk Res, 9, pp. 1017-1021.
18. Kohn, FR, Landkamer, GJ and Manthey, CL (1987) Effect of aldehyde dehydrogenase inhibitors on the ex vivo sensitivity of human multipotent and committed hematopoietic progenitor cells and malignant blood cells to oxazaphosphorines. Cancer Res, 47, pp. 3180-3185.
19. Rowley, SD, Colvin, OM and Stuart, RK. (1985) Human multilineage progenitor cell sensitivity to 4-hydroperoxycyclophosphamide. Exp Hematol, 13, pp. 295-298.
20. Ratajczak, MZ, Ratajczak, J. and Kuczynski, W. (1993) In vitro sensitivity of human hematopoietic progenitor cells to 4-hydroperoxycyclophosphamide. Exp Hematol, 21, pp. 1663-1667.